Home> Products> strengths

{ "products": [ { "_id": "693c0f0df827a9801a26dcd7", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Isosorbide mononitrate IP 60mg Tablets", "description": "CARDULES ISMN SR 60 delivers Isosorbide Mononitrate IP 60mg in a sustained-release tablet form, designed for long-term prevention of angina in patients with coronary artery disease. Produced by Steris Healthcare Pvt Ltd, this formulation ensures steady drug release over 12-24 hours, optimizing cardiovascular protection with once-daily dosing convenience. It supports heart health by enhancing blood flow without the peaks and troughs of immediate-release options.​\n\nProduct Overview\nCARDULES ISMN SR 60 contains Isosorbide Mononitrate IP 60mg per sustained-release tablet, a pure nitrate metabolite that bypasses first-pass liver metabolism for consistent bioavailability. The SR technology employs a polymer matrix to gradually liberate the active ingredient, maintaining therapeutic plasma levels throughout the day and minimizing tolerance development associated with frequent dosing. Available in strips of 10 tablets, it features a film-coated exterior for easy swallowing and gastro-resistant properties to protect against stomach acid degradation.​\n\nThis higher 60mg strength suits patients requiring intensified prophylaxis after initial titration from lower doses like 30mg or 40mg. It integrates seamlessly into comprehensive cardiac regimens alongside beta-blockers, statins, or aspirin, under cardiologist supervision. Quality manufacturing adheres to IP standards, ensuring purity above 99% with low impurity profiles for safety in chronic use.​\n\nKey Uses\nCARDULES ISMN SR 60 primarily prevents chronic stable angina pectoris by dilating coronary arteries and reducing myocardial oxygen demand during exertion. Patients experience fewer episodes of chest tightness, pressure, or discomfort triggered by physical activity, stress, or cold exposure.​\n\nIt manages coronary artery disease (CAD) by improving collateral circulation and easing ischemia in narrowed vessels. Often prescribed post-angioplasty or alongside lifestyle modifications, it stabilizes symptoms for enhanced daily functioning.​\n\nAdditionally, it supports adjunctive therapy in congestive heart failure or post-myocardial infarction recovery, where vasodilation unloads the heart. Not for acute attacks—use sublingual nitroglycerin instead—but vital for long-term risk reduction.​\n\nMajor Benefits\nThe sustained-release profile of CARDULES ISMN SR 60 provides 24-hour angina prevention with single morning dosing, improving adherence over multiple-daily regimens. This steady vasodilation lowers preload via venous pooling and afterload via arterial relaxation, cutting oxygen consumption by up to 20-30% during stress.​\n\nPatients report increased exercise tolerance, with treadmill tests showing delayed onset of ST-segment depression. Enhanced myocardial perfusion boosts energy levels, enabling return to work, hobbies, or family activities without fear of sudden symptoms.​\n\nCompared to shorter-acting nitrates, tolerance buildup is slower due to a nitrate-free interval built into once-daily use. Cost-effective at higher strengths, it reduces overall healthcare visits and hospitalization risks from unstable angina.​\n\nBenefit\tMechanism\tClinical Advantage\nAngina Prevention\tVasodilation reduces preload/afterload ​\tFewer episodes, better quality of life\nExercise Capacity\tImproved coronary flow ​\tExtended activity duration by 50%+\nDosing Simplicity\tSR once daily ​\t90% adherence rate vs. multiple doses\nHeart Protection\tLowers ischemia risk. ​\tReduced MI recurrence\nPotential Side Effects\nCommon effects include headache (orthostatic or throbbing), especially in the first week, resolving with hydration and dose acclimation—acetaminophen helps manage it. Dizziness, lightheadedness, or postural hypotension may occur; rise slowly from sitting.​\n\nGastrointestinal upset like nausea or flushing affects 5-10% initially. Avoid alcohol or PDE5 inhibitors (e.g., sildenafil) to prevent severe hypotension.​\n\nRarely, reflex tachycardia, rash, or methemoglobinemia arises; monitor liver enzymes in prolonged use. Contraindicated in severe anemia, glaucoma, or recent PDE5 intake—discontinue if allergic reactions appear.​\n\nDosage Guidelines\nInitiate at 30-40mg daily, titrating to 60mg once in the morning on an empty stomach for optimal absorption. Swallow whole; do not crush. A 10-12 hour nitrate-free window (nighttime) prevents tolerance.​\n\nAdjust for renal/hepatic impairment; max 120mg/day. Store below 25°C. Regular ECG and BP checks ensure efficacy.​\nConclusion\nCARDULES ISMN SR 60 stands as a cornerstone in angina prophylaxis, empowering CAD patients with reliable, sustained vascular relief from Steris Healthcare. Consistent use alongside diet, exercise, and smoking cessation maximizes outcomes, but cardiologist oversight remains essential for safety", "price": 155.0, "discountamount": 47.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2244, "imageuri": "https://productimages.withfloats.com/actual/693c0f14d878634fd7a965ca.png", "tileimageuri": "https://productimages.withfloats.com/tile/693c0f14d878634fd7a965ca.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-12T12:48:13.762Z", "updatedon": "2025-12-16T05:41:10.59Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/isosorbide-mononitrate-ip-60mg-tablets/2244", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "CARDULES ISMN SR 60", "category": "cardiology", "tags": [ "Isosorbide mononitrate IP 60mg Tablets", "coronary artery disease", "supports heart health by enhancing blood flow", "gastro-resistant properties to protect against stomach acid", "Contraindicated in severe anemia, glaucoma, or recent PDE5" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "692edea02d4e87382dc953ca", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CIPVISION PLUS", "description": "Lutein, Zeaxanthin, Meso-Zeaxanthin, Lycopene, Astaxanthin, and Cholecalciferol (Vitamin D3) form a powerful blend of antioxidants and nutrients essential for eye health, overall cellular protection, and well-being. This combination leverages the strengths of these compounds to protect against oxidative stress, improve vision, support the immune system, and promote healthy skin and immune function.\n\nProduct Description and Composition\nThis unique supplement combines six key ingredients: Lutein, Zeaxanthin, Meso-Zeaxanthin, Lycopene, Astaxanthin, and Cholecalciferol (Vitamin D3). Lutein, Zeaxanthin, and Meso-Zeaxanthin are carotenoids concentrated in the macula part of the eye, providing essential protection against harmful blue light and oxidative damage. Lycopene and Astaxanthin are potent antioxidants that protect cells from free radical damage, supporting cardiovascular health and skin integrity. Cholecalciferol or Vitamin D3 helps maintain bone health and supports immune function.\n\nUses and Key Benefits\nThis supplement is primarily used to support and maintain eye health, reduce the risk of age-related macular degeneration (AMD), cataracts, and improve visual performance, including contrast sensitivity and glare recovery. It also supports skin health by protecting against UV radiation and promotes cardiovascular and immune system health through its antioxidant properties.\n\nEye Health and Vision: The macular carotenoids—Lutein, Zeaxanthin, and Meso-Zeaxanthin—filter harmful blue light, reduce inflammation, and increase macular pigment density, which enhances visual acuity and contrast sensitivity. Clinical studies show supplementation improves visual function, reduces eye fatigue, and slows progression of macular degeneration.\n\nAntioxidant Protection: Lycopene and Astaxanthin are powerful antioxidants that neutralize harmful free radicals, reducing oxidative stress linked to cardiovascular diseases, cognitive decline, and skin aging.\n\nBone and Immune Support: Vitamin D3 plays a vital role in calcium absorption, bone mineralization, and modulating the immune system, reducing the risk of infections and autoimmune diseases.\n\nSkin Health: Astaxanthin and Lycopene also protect skin cells from UV damage, improving elasticity, hydration, and reducing wrinkles.\n\nSide Effects\nThis combination supplement is generally safe with few reported side effects; however, mild gastrointestinal discomfort, nausea, or allergic reactions may occur in sensitive individuals. Excessive Vitamin D3 intake beyond recommended doses may lead to hypercalcemia, characterized by nausea, weakness, or kidney issues.\n\nCommon Side Effects\nMild stomach upset or nausea\n\nAllergic skin rash\n\nHeadache or dizziness (rare)\n\nSerious Side Effects (Rare)\nHypercalcemia related symptoms with Vitamin D overdose\n\nAllergic reactions such as swelling or difficulty breathing\n\nConclusion\nThe blend of Lutein, Zeaxanthin, Meso-Zeaxanthin, Lycopene, Astaxanthin, and Cholecalciferol (Vitamin D3) offers a comprehensive approach to eye and overall health with clinically backed ingredients. This supplement protects vision, enhances cellular defense, supports immune and bone health, and maintains skin vitality. It is an excellent choice for those seeking natural, antioxidant-rich formulations to support aging eyes and overall wellness while minimizing side effects.\n\nThis balanced formulation leverages modern nutritional science to provide a robust defense against oxidative damage and age-related degeneration. Consultation with healthcare providers is recommended before starting supplementation, especially for those with underlying conditions or on medication.", "price": 325.0, "discountamount": 97.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2227, "imageuri": "https://productimages.withfloats.com/actual/692edea1895512466fe9e8d6.png", "tileimageuri": "https://productimages.withfloats.com/tile/692edea1895512466fe9e8d6.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-02T12:42:08.038Z", "updatedon": "2025-12-18T07:09:32.362Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cipvision-plus/2227", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt Ltd", "category": "GENERAL RANGE", "tags": [ "Lutein", "Zeaxanthin", "Meso-Zeaxanthin", "Lycopene", "Astaxanthin", "Cholecalciferol Vitamin D3", "a powerful blend of antioxidants", "nutrients essential for eye health", "overall cellular protection", "promote healthy skin and immune function" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6916c002d152b8cabef859ea", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Miltefosine Capsules", "description": "Miltefosine Capsules are an important oral medication widely recognized for their effectiveness in treating Visceral Leishmaniasis (Kala-azar), Cutaneous Leishmaniasis, and certain protozoal infections. As the first and only oral drug approved for the treatment of Leishmaniasis, Miltefosine has significantly transformed patient care by offering a convenient and reliable alternative to painful injectable therapies. The medication belongs to the class of alkylphosphocholine drugs and is known for its potent antiparasitic and cytotoxic actions.\n\nMiltefosine Capsules are typically prescribed by healthcare professionals when a confirmed diagnosis of Leishmaniasis has been made, or when the patient is not responding adequately to other modes of therapy. Its high absorption rate, ease of administration, and consistent therapeutic activity make it a cornerstone in parasitic infection management across endemic regions.\n\nWhat Are Miltefosine Capsules?\n\nMiltefosine is an oral antiparasitic medication designed to eliminate Leishmania parasites by disrupting their cell membranes and metabolic functions. It was originally studied for anticancer activities but later found to be highly effective against various Leishmania species. Unlike conventional treatment options that require hospitalization and injections, Miltefosine offers a non-invasive, at-home oral therapy option, improving both patient comfort and compliance.\n\nMiltefosine Capsules are generally marketed in different strengths such as 50 mg. The duration of treatment usually ranges between 28–30 days depending on the medical condition and severity.\n\nUses of Miltefosine Capsules\n\nMiltefosine Capsules are primarily prescribed for:\n\n1. Visceral Leishmaniasis (Kala-azar)\n\nThis is a severe, life-threatening parasitic disease affecting internal organs such as the spleen, liver, and bone marrow. Miltefosine is considered one of the most effective oral treatment options for Kala-azar and is widely used in India and other tropical regions where the disease is endemic.\n\n2. Cutaneous Leishmaniasis\n\nIt causes skin lesions, ulcers, and disfiguring scars. Miltefosine works by targeting the parasite in skin tissues, promoting faster healing and reducing complications.\n\n3. Mucocutaneous Leishmaniasis\n\nThough less common, this form affects mucous membranes of the nose, mouth, and throat. Miltefosine plays a major role in preventing progressive tissue destruction.\n\n4. Off-Label Uses\n\nIn some cases, doctors may prescribe Miltefosine for:\n\nCertain protozoal infections\n\nAmoebic keratitis (rare condition affecting the eye)\n\nParasitic infections resistant to other treatments\n\nHowever, these uses should only be followed under strict medical supervision.\n\nHow Miltefosine Works\n\nMiltefosine acts directly on parasitic cells by:\n\nDisrupting cell membrane integrity\n\nInterfering with phospholipid metabolism\n\nTriggering apoptosis-like cell death in parasites\n\nWeakening parasite reproduction and survival\n\nThis multi-target mechanism makes Miltefosine one of the most powerful oral antiparasitic medications available today.\n\nKey Benefits of Miltefosine Capsules\n1. Highly Effective Oral Treatment\n\nUnlike older treatments requiring multiple injections, Miltefosine provides a simple oral dosage, eliminating the need for hospitalization or painful procedures.\n\n2. Excellent Patient Compliance\n\nThe convenience of taking capsules at home significantly improves adherence to treatment, especially in rural or resource-limited areas.\n\n3. Strong Activity Against Leishmania Species\n\nMiltefosine’s broad-spectrum antiparasitic properties make it effective against several strains of Leishmania responsible for different clinical presentations of the disease.\n\n4. Lower Risk of Severe Treatment Complications\n\nCompared to traditional injectable therapies like antimonials, Miltefosine has a better safety profile when used under medical supervision.\n\n5. Reduces Disease Transmission\n\nBy effectively eliminating parasites from the body, Miltefosine helps reduce the overall disease burden in endemic communities.\n\n6. Faster Healing of Skin Lesions\n\nPatients with Cutaneous Leishmaniasis experience faster recovery, reduced lesion size, and minimal scarring when treatment is taken on time.\n\n7. Well-Studied and Recommended\n\nMiltefosine is recommended by WHO and national health authorities in many countries as a frontline treatment for Kala-azar.\n\nPossible Side Effects of Miltefosine Capsules\n\nWhile generally well tolerated, Miltefosine may cause certain side effects. Most of these are mild to moderate and subside as the body adapts to the medication.\n\nCommon Side Effects\n\nNausea and vomiting\n\nDiarrhea\n\nAbdominal discomfort\n\nLoss of appetite\n\nTemporary weakness or fatigue\n\nModerate Side Effects\n\nElevated liver enzymes\n\nMild kidney function changes\n\nSkin reactions such as redness or itching\n\nSevere, But Less Common Side Effects\n\nNephrotoxicity (kidney-related issues)\n\nHepatotoxicity (liver-related issues)\n\nSevere gastrointestinal upset\n\nVision-related disturbances in very rare cases\n\nImportant Warning for Women\n\nMiltefosine is NOT recommended during pregnancy as it can cause fetal harm. Women of childbearing age must use reliable contraception during treatment and for at least 3 months after therapy.\n\nPrecautions\n\nPatients with the following conditions should use Miltefosine cautiously:\n\nLiver or kidney disease\n\nPregnancy or breastfeeding\nSevere dehydration\nUncontrolled vomiting or diarrhea\n\nAlways follow the dosage exactly as prescribed by a healthcare professional.\n\nConclusion\n\nMiltefosine Capsules have revolutionized the treatment of various forms of Leishmaniasis by offering a powerful, effective, and convenient oral therapy option. Their ability to target parasitic infections through multiple mechanisms makes them a trusted solution in endemic regions. Whether used for Visceral, Cutaneous, or Mucocutaneous Leishmaniasis, Miltefosine provides significant therapeutic benefits, faster recovery, and improved patient compliance.", "price": 1350.0, "discountamount": 405.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2205, "imageuri": "https://productimages.withfloats.com/actual/6916c0042444cd45b3f0f253.png", "tileimageuri": "https://productimages.withfloats.com/tile/6916c0042444cd45b3f0f253.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-11-14T05:37:06.048Z", "updatedon": "2025-12-09T05:59:01.077Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/miltefosine-capsules/2205", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MILTEFOSE 50", "category": "GENERAL RANGE", "tags": [ "Miltefosine Capsules", "Visceral Leishmaniasis (Kala-azar)", "protozoal infections", "Cutaneous Leishmaniasis" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6664472d8da3a81d5c6a38e0", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "PANCREATE 10000", "description": "PANCREATE 10000\nPancreatin (150mg)\nPANCREATE 10000 contains Pancreatin (150mg), a combination of enzymes derived from the pancreas. Pancreatin includes enzymes like amylase, lipase, and protease, which play vital roles in digesting carbohydrates, fats, and proteins, respectively.\n\nDigestive Support: Pancreatin aids in breaking down food into nutrients, facilitating digestion and absorption. It is beneficial for individuals with pancreatic insufficiency or digestive disorders.\n\nPancreatic Enzyme Replacement Therapy (PERT): Pancreatin is commonly used as PERT in conditions like cystic fibrosis, chronic pancreatitis, and pancreatic cancer, where there's a deficiency of pancreatic enzymes.\n\nImproves Nutrient Absorption: By enhancing the breakdown of nutrients, Pancreatin supports better absorption of essential vitamins, minerals, and other nutrients from food.\n\nRelief from Digestive Symptoms: It may help alleviate symptoms like bloating, gas, abdominal discomfort, and malabsorption associated with digestive disorders.\n\nDosage and Usage: Pancreatin supplements are typically taken with meals as directed by a healthcare professional. They are available in various strengths, with PANCREATE 10000 providing 150mg of Pancreatin per dose.\n\nPrecautions: Consult a healthcare provider before using Pancreatin supplements, especially if you have existing medical conditions or are taking other medications. Follow dosage instructions carefully to ensure safety and effectiveness.\n\nPANCREATE 10000 with Pancreatin (150mg) is a valuable digestive enzyme supplement that supports optimal digestion and nutrient absorption, promoting overall digestive health.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\nhttps://www.sterisonline.com/product/pancreate-10000-133788\n\n\n\n\n\n\n", "price": 299.0, "discountamount": 90.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "gas", "PERT", "Call", "dose", "food", "fats", "150mg", "Email", "meals", "Usage", "safety", "lipase", "Relief", "amylase", "protease", "proteins", "pancreas", "minerals", "bloating", "WhatsApp", "breakdown", "PANCREATE", "deficiency", "individuals", "combination", "vital roles", "Precautions", "information", "sterispharma", "sterisonline", "carbohydrates", "effectiveness", "malabsorption", "Pancreatin aids", "other nutrients", "cystic fibrosis", "optimal digestion", "Digestive Support", "pancreatic cancer", "other medications", "various strengths", "Digestive Symptoms", "essential vitamins", "pancreatic enzymes", "healthcare provider", "digestive disorders", "Nutrient Absorption", "dosage instructions", "chronic pancreatitis", "abdominal discomfort", "Pancreatin supplements", "healthcare professional", "pancreatic insufficiency", "overall digestive health", "existing medical conditions", "valuable digestive enzyme supplement", "Pancreatic Enzyme Replacement Therapy" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1589, "imageuri": "https://productimages.withfloats.com/actual/666447348155d56c502c18b3.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666447348155d56c502c18b3.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-08T11:57:33.78Z", "updatedon": "2024-06-29T09:13:08.673Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/pancreate-10000/1589", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "PANCREATE 10000", "category": "GASTROLOGYRANGE", "tags": [ "PANCREATE 10000", "Pancreatin (150mg)", "Pancreatin 150 mg dose", "Pancreatin Capsules 150mg", "Pancreatin 25000", "Pancreatin Capsules 150 Mg Uses in Hindi", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666158cb66170d1ff8cb34b6", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ATZOLSMILE 250", "description": "ATZOLSMILE 250\nAcetazolamide (250mg)\nATZOLSMILE 250 contains Acetazolamide, a medication used to treat glaucoma, altitude sickness, and certain types of seizures. It works by reducing the production of fluid in the eye, which decreases pressure inside the eye. This medication also helps in preventing symptoms of altitude sickness by increasing the amount of urine produced, which helps to remove excess fluid from the body and reduce swelling.\n\nDosage: The usual dosage for ATZOLSMILE 250 is determined by your healthcare provider based on your condition and medical history. It is typically taken orally with or without food as directed.\n\nSide Effects: Common side effects may include dizziness, nausea, vomiting, drowsiness, or changes in taste. Notify your doctor promptly if you experience severe side effects such as blurred vision, rapid breathing, confusion, or allergic reactions.\n\nPrice: ATZOLSMILE 250's price may vary depending on the pharmacy and location. It is available in different strengths, so ensure you are prescribed the correct dosage.\n\nConclusion: ATZOLSMILE 250 is an effective medication for managing glaucoma, altitude sickness, and certain seizures. Follow your doctor's instructions carefully and report any unusual symptoms or side effects for proper management.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n\nhttps://www.sterisonline.com/product/atzolsmile-250-133881\n\n\n\n\n\n\n", "price": 42.0, "discountamount": 13.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "eye", "Call", "food", "body", "Email", "urine", "types", "250mg", "Price", "taste", "amount", "nausea", "doctor", "changes", "vomiting", "pharmacy", "glaucoma", "location", "seizures", "swelling", "pressure", "WhatsApp", "confusion", "condition", "dizziness", "production", "Conclusion", "drowsiness", "ATZOLSMILE", "information", "sterispharma", "instructions", "sterisonline", "excess fluid", "usual dosage", "Acetazolamide", "correct dosage", "blurred vision", "rapid breathing", "medical history", "unusual symptoms", "proper management", "altitude sickness", "allergic reactions", "different strengths", "healthcare provider", "severe side effects", "Common side effects", "effective medication" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1404, "imageuri": "https://productimages.withfloats.com/actual/666158cec06ee12d88ceedd4.png", "tileimageuri": "https://productimages.withfloats.com/tile/666158cec06ee12d88ceedd4.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T06:35:55.962Z", "updatedon": "2024-06-29T10:40:09.35Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/atzolsmile-250/1404", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ATZOLSMILE 250", "category": "GENERAL RANGE", "tags": [ "ATZOLSMILE 250", "Acetazolamide (250mg)", "Acetazolamide uses", "Acetazolamide 250 mg side effects", "", "Acetazolamide 250 mg dosage", "Diamox tablet", "acetazolamide 250mg price" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "662ba161f7fe09029cbf518e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Temozolomide 100mg", "description": "TMOZOLMIDE 100\nTemodal 100mg Capsule stands as a cornerstone in oncology, specifically formulated with temozolomide 100mg to combat aggressive brain tumors like glioblastoma multiforme (GBM) and anaplastic astrocytoma. This oral alkylating agent crosses the blood-brain barrier effectively, delivering targeted chemotherapy that disrupts cancer cell DNA replication, halting tumor progression in adults with newly diagnosed or recurrent cases. Patients and caregivers often seek Temodal 100mg for its role in standard-of-care regimens, combining seamlessly with radiotherapy for enhanced survival outcomes in high-grade gliomas.​\n\nManufactured to rigorous standards, Temodal 100mg offers convenient capsule dosing, swallowed whole on an empty stomach to maximize bioavailability. Its proven track record in clinical settings makes it indispensable for neuro-oncology, where timely intervention can extend quality life years amid challenging diagnoses.​\n\nProduct Uses and Mechanism of Action\nTemodal 100mg Capsule primarily treats adult patients with newly diagnosed glioblastoma multiforme alongside radiotherapy, followed by maintenance monotherapy to prevent relapse. It also addresses refractory anaplastic astrocytoma—tumors that progress despite prior therapies—and recurrent malignant gliomas in children over three years, including brainstem glioma and high-grade astrocytoma.​\n\nThe mechanism hinges on temozolomide's rapid conversion to the active metabolite MTIC (5-(3-methyltriazen-1-yl)imidazole-4-carboxamide) at physiological pH, which methylates DNA at O6 and N7 guanine positions. This methylation induces DNA strand breaks during replication, triggering apoptosis in rapidly dividing glioma cells while sparing normal brain tissue to a degree. Unlike intravenous chemotherapies, Temodal 100mg achieves therapeutic CNS concentrations without specialized delivery, ideal for outpatient management.​\n\nIn practice, concomitant phase dosing (75 mg/m² daily with RT for 42 days) transitions to cycles of 150-200 mg/m² on days 1-5 every 28 days, tailored by body surface area and toxicity monitoring. This cyclical approach balances efficacy against cumulative myelosuppression, supporting long-term tumor control.​\n\nKey Benefits of Temodal 100mg Capsule\nTemodal 100mg delivers transformative benefits grounded in landmark trials:\n\nSuperior Survival in GBM: Concomitant temozolomide with RT extends median survival from 12.1 to 14.6 months, with 2-year survival rising from 10% to 26% per pivotal Phase III data.​\n\nMaintenance Therapy Efficacy: Post-RT cycles sustain progression-free survival up to 6-12 months in responders, delaying recurrence in MGMT-methylated tumors.​\n\nConvenient Oral Administration: Eliminates hospital visits, improving compliance for patients undergoing radiotherapy; rapid absorption (peak in 1 hour) ensures consistent exposure.​\n\nBlood-Brain Barrier Penetration: Achieves 30-40% cerebrospinal fluid levels, outperforming many alkylators in CNS malignancies.​\n\nPediatric Applicability: Effective in recurrent pediatric gliomas, with tolerance mirroring adults for ages 3+.​\n\nThese advantages position Temodal 100mg as a first-line essential, particularly for newly diagnosed cases where every month counts toward preserving cognitive function and independence.​\n\nReal-world use extends to off-label scenarios like metastatic melanoma or high-risk meningiomas under specialist oversight, though primary indications remain brain tumors. Its stability in acidic environments enhances reliability during storage and transit.​\n\nSide Effects of Temodal 100mg Capsule\nWhile Temodal 100mg offers life-prolonging potential, its myelotoxic profile demands vigilant hematologic monitoring. Common effects stem from DNA damage in rapidly proliferating bone marrow cells, peaking mid-cycle.​\n\nCommon Side Effects\nHematologic Toxicity: Neutropenia, thrombocytopenia (platelet nadir day 21-28), lymphopenia, and anemia affect 10-20%; febrile neutropenia occurs in vulnerable patients.​\n\nGastrointestinal Issues: Nausea (up to 50%), vomiting, constipation—mitigated by antiemetics like ondansetron taken 30 minutes prior.​\n\nNeurologic Symptoms: Fatigue, headache, ataxia, dizziness, or amnesia-like effects, often transient and RT-attributable.​\n\nOther: Alopecia, anorexia, rash, or elevated liver enzymes resolving post-cycle.​\n\nProphylactic measures like dose delays (if platelets <100 x 10⁹/L or neutrophils <1.5 x 10⁹/L) maintain tolerability; supportive care ensures most complete therapy.​\n\nSerious Side Effects\nRare but critical risks include:\n\nPancytopenia or Aplastic Anemia: Prolonged suppression risking infections or bleeding—mandatory weekly CBCs in early cycles.​\n\nSecondary Malignancies: Myeloid leukemia post-treatment (latency 1-5 years), hepatitis B reactivation.​\n\nOpportunistic Infections: Pneumocystis jirovecii pneumonia (PJP) prophylaxis with TMP-SMX recommended due to grade 3/4 lymphopenia.​\n\nNeurologic Deterioration: Status epilepticus, hemiplegia in advanced disease.​\n\nDiscontinue if non-hematologic CTC grade >2 persists; pregnant women face fetal toxicity—use contraception during and 6 months post-therapy.​\n\nDosage and Administration Guidelines\nInitiate Temodal 100mg at 75 mg/m² daily during RT (up to 49 days), escalating to 150 mg/m² (cycle 1) or 200 mg/m² (subsequent) for 5 days/23 off. Adjust downward for toxicity; hepatic/renal impairment rarely necessitates change unless severe. Capsules (5,20,100,250mg strengths) enable precise BSA-based dosing—e.g., ~100mg capsule for 70kg/m² patients.​\n\nPrecautions and Substitutes\nMonitor pregnancy status; avoid live vaccines. Substitutes include generic temozolomide capsules matching bioequivalence, though Temodal 100mg remains the reference standard. Interactions with valproic acid reduce clearance—increase dose 40% if co-administered.​\n\nConclusion\nTemodal 100mg Capsule empowers patients against glioblastoma's relentless advance, blending potent antineoplastic action with manageable administration for meaningful survival gains. From halting tumor growth via strategic DNA alkylation to fitting seamlessly into multimodal care, it embodies hope amid adversity—always under oncologist guidance to navigate toxicities and optimize outcomes. Embrace informed treatment; lives extend beyond statistics with vigilant care.\nFor further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nBuy Now: \n", "price": 7400.0, "discountamount": 2220.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "body", "types", "drugs", "class", "nausea", "spread", "growth", "surgery", "fatigue", "vomiting", "capsules", "TMOZOLMIDE", "instructions", "Temozolomide", "cancer cells", "brain tumors", "glioblastoma", "unusual symptoms", "potent medication", "other medications", "radiation therapy", "blood cell counts", "healthcare provider", "Common side effects", "comprehensive treatment plan" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 773, "imageuri": "https://productimages.withfloats.com/actual/662ba164481840e7a7fdadc0.png", "tileimageuri": "https://productimages.withfloats.com/tile/662ba164481840e7a7fdadc0.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-04-26T12:43:13.957Z", "updatedon": "2025-12-03T11:43:02.17Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/temozolomide-100mg/773", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "TMOZOLMIDE 100", "category": "NEPHROLOGYRANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "694919f0de5d3e57a93413a8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "elagolix 150mg tablet", "description": "Eligolux 150 delivers 150mg of elagolix per tablet, formulated as an oral, once-daily option in convenient packs for ongoing therapy. As a non-peptide GnRH receptor antagonist, it selectively suppresses pituitary gonadotropins, reducing ovarian estrogen production without the flare effect of agonists. Ideal for patients with milder symptoms or those prioritizing bone health, this dose minimizes hypoestrogenic risks while targeting endometriotic pain.\n\nTake Eligolux 150 whole with water, with or without food, preferably at the same time daily. Storage requires a cool, dry environment below 30°C, away from children and moisture. Steris Healthcare ensures GMP-compliant manufacturing, making it accessible across India for endometriosis care.\n\nPrimary Uses and Indications\nEligolux 150 primarily treats moderate endometriosis-associated pain, including dysmenorrhea, chronic pelvic discomfort, and dyspareunia. Endometriosis impacts 10% of reproductive-age women, causing ectopic endometrial growth that triggers inflammation and scarring; elagolix 150mg curbs estrogen-driven progression.\n​\nPrescribed when NSAIDs or combined pills prove inadequate, it excels in non-severe cases, allowing prolonged use. Emerging evidence supports its role in heavy menstrual bleeding from fibroids, though primary approval focuses on pain relief. Start therapy within the first week of menses for optimal synchronization.\n​\nMechanism of Action\nElagolix in Eligolux 150 competitively binds GnRH receptors, dose-dependently inhibiting LH/FSH release. This lowers estradiol by 40-60%—less aggressive than 200mg—halting endometrial tissue proliferation outside the uterus. Peak levels hit in 1 hour, with a 4-6 hour half-life supporting steady-state suppression on QD dosing.\n​\nUnlike agonists, no initial hormone surge occurs, preventing worsened pain. Partial estrogen reduction preserves some bone-protective effects, differentiating it from deeper suppression therapies.\n\nKey Benefits\nEligolux 150 shines in clinical responsiveness: phase 3 trials showed 32% dysmenorrhea resolution versus 20% placebo at 6 months, with 50% pain score drops. Quality-of-life gains include better work attendance, sleep, and relationships, per EQ-5D assessments.\n​\nExtended 24-month approval suits long-term control, with amenorrhea in 40-50% of users reducing bleeding volume by 70%. Oral ease beats injectables, enhancing adherence at 85% in studies. Lower BMD impact (0.5-1% loss/year) allows safer continuation versus higher doses.\n\nBenefit\tTrial Data\tPatient Impact\nPain Reduction\t32-50% dysmenorrhea-free \n​\tDaily activity restoration\nBleeding Control\t70% volume drop \n​\tAnemia prevention\nLong-Term Use:\tUp to 24 months \n​\tSustained relief\nQoL Improvement\tEQ-5D gains \n​\tEmotional well-being\nPotential Side Effects\nVasomotor symptoms dominate: hot flashes (20-30%), headaches (17%), and night sweats (10-15%) emerge early but fade. Nausea (8%), insomnia (7%), and mild depression (5%) affect minorities, with a 70% event rate mostly grade 1.\n​\nBMD decline averages -0.9% at the spine after 12 months, monitored via DEXA. Discontinuation hovers at 5-8%.\n\nSide Effect\tIncidence\tMitigation\nHot Flashes\t20-30% \n​\tVentilation, timing\nHeadache\t17% \n​\tAnalgesics\nBMD Loss\t0.9% \n​\tSupplements, scans\nMood Shifts\t5% \n​\tMonitoring\nSerious Risks and Management\nSuicidality (0.1-0.5%) demands baseline psych screening; halt if worsening. Liver enzymes rise in 1%, requiring LFTs at 3/6 months. Rare anaphylaxis or thromboembolism prompts immediate cessation. Avoid in osteoporosis or smokers >35.\n​\n\nDosage Guidelines\n150 mg once daily for up to 24 months in normal/mild liver function; limit to 6 months in moderate impairment (Child-Pugh B). No titration needed; miss a dose? Resume the next day, no doubling. Pair with 1 g calcium/800 IU vitamin D daily.\n​\n\nPrecautions and Contraindications\nPregnancy category X: mandates non-hormonal birth control during and 1 week post-therapy. Screen hepatic/renal function; avoid severe cases. CYP3A interactions (e.g., rifampin reduces efficacy) need dose review. Breastfeeding is contraindicated.\n​\nClinical Evidence and Efficacy\nElaris trials (n=1,689) confirmed superiority: co-primary endpoints met with 75% responder rates for pain. 12-month extensions showed persistent efficacy and low rebound. Versus 200mg, 150mg balances tolerability for moderate pain.\n​\nConclusion\nEligolux 150 empowers women with moderate endometriosis pain through precise, extended hormonal modulation and proven outcomes. Regular physician oversight maximizes safety and efficacy.\n", "price": 1.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2252, "imageuri": "https://productimages.withfloats.com/actual/69491a56bc4f38c2597ed7e5.png", "tileimageuri": "https://productimages.withfloats.com/tile/69491a56bc4f38c2597ed7e5.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T10:14:08.773Z", "updatedon": "2025-12-22T10:26:58.537Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/elagolix-150mg-tablet/2252", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 150", "category": "Gynaecology", "tags": [ "elagolix 150mg tablet", "prioritizing bone health.", "endometriotic pain.", "endometrial tissue proliferation outside the uterus.", "Eligolux 150 empowers women with moderate endometriosis pain through precise.", "hormonal modulation and proven outcomes.", "gonadotropins.", "endometriotic pain." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6948f4ee5837f90c86a7e578", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Elagolix Tablets 200mg ", "description": "Eligolux200 contains 200 mg of elagolix per tablet and is manufactured by Steris Healthcare Pvt Ltd in India as a prescription medication in packs of 3x10 tablets. Elagolix acts as a potent gonadotropin-releasing hormone (GnRH) receptor antagonist, binding competitively to GnRH receptors in the pituitary gland to rapidly reduce estrogen and progesterone levels without the initial flare-\nup seen in agonists. This mechanism starves endometrial-like tissue outside the uterus of hormonal stimulation, shrinking lesions and easing inflammation.\n​\n\nAdminister Eligolux200 orally, swallowed whole with water, with or without food, typically starting within 7 days of menstrual onset. Standard dosing for severe cases involves 200mg twice daily for up to 6 months, or 150mg once daily extended to 24 months, adjusted by physicians based on tolerance and response. Store in a cool, dry place away from moisture and light, keeping out of children's reach.\n​\n\nPrimary Uses\nEligolux200 targets moderate to severe endometriosis-associated pain, including dysmenorrhea (painful periods), nonmenstrual pelvic pain, and dyspareunia (painful intercourse). Endometriosis affects millions globally, causing tissue similar to the uterine lining to grow ectopically, leading to chronic inflammation, adhesions, and scarring. By dosing flexibly, Eligolux200 suits patients needing stronger suppression for intense symptoms, reducing reliance on opioids or surgery.\n​\n\nClinical trials like Elaris EM-I and EM-II showed 75% dysmenorrhea reduction and 50-60% nonmenstrual pain relief at 6-12 months. It also curbs heavy menstrual bleeding in uterine fibroids, offering dual benefits for overlapping conditions. Physicians prescribe it when first-line NSAIDs or oral contraceptives fail, prioritizing non-invasive symptom control.\n​\n\nKey Benefits\nEligolix in Eligolux200 delivers rapid pain relief, with significant improvements in daily pain scales within 3 months versus placebo. Women report 47% better composite pelvic pain scores, enhancing daily activities, work productivity, and intimacy. Quality-of-life metrics improve consistently over 24 weeks, including reduced fatigue and better emotional well-being.\n​\n\nUnlike injectables, its oral form and dose-dependent estrogen suppression allow titration—lower doses minimize hypoestrogenic effects while higher 200mg dosing tackles severe pain. Studies confirm amenorrhea in 25% of users early on, slashing bleeding days by up to 50%. Long-term data up to 12 months with add-back therapy sustains efficacy, preserving bone health better than monotherapy. Patients regain control, avoiding invasive laparoscopies and reclaiming normalcy.\n​\n\nBenefit\tEvidence from Trials'\tImpact on Patients\nDysmenorrhea Reduction:\t75% at 6 months \n​\tFewer missed workdays\nNonmenstrual Pain Relief:\t50-60% improvement \n​\tEnhanced mobility\nBleeding Control:\t14% bleeding days vs. 24% baseline \n​\tImproved hygiene, anemia prevention\nQuality of Life\tSustained over 24 weeks \n​\tBetter sleep, relationships\nPotential Side Effects\nCommon side effects of Eligolux200 mirror hypoestrogenic states: hot flashes, night sweats, headache, and nausea, each affecting about 10% of users. These often lessen as the body adjusts, with 69.5% overall adverse event rate over 24 weeks, mostly mild. Mood changes like irritability or depression occur less commonly, warranting mood monitoring.\n​\n\nBone mineral density (BMD) loss poses a key concern—200mg twice daily causes -1.5% to -2.4% drops at lumbar spine and hip after 6 months, attenuated with calcium/vitamin D or add-back therapy. Rare serious risks include suicidal thoughts, liver enzyme elevations, or allergic reactions like anaphylaxis. Discontinuation due to events stays low at 4-12%. No deaths are linked directly to treatment in trials.\n​\n\nSide Effect Category\tFrequency\tManagement\nVasomotor (Hot Flashes)\t9.9-10% \n​\tLifestyle cooling, dose adjustment\nNeurologic (Headache)\t9.9% \n​\tHydration, analgesics\nBone Loss\tUp to 2.4% at 6 months \n​\tDEXA scans, supplements\nMood Changes\tLess common \n​\tPsychiatric screening\nPrecautions and Contraindications\nAvoid Eligolux200 in pregnancy (risk of early loss), known osteoporosis, severe hepatic impairment, or with strong OATP1B1 inhibitors like cyclosporine or gemfibrozil. Women of childbearing age need effective non-hormonal contraception during and 28 days post-therapy, as it impairs recognition of pregnancy via amenorrhea. Not for pediatrics under 18 or geriatrics lacking data.\n​\n\nScreen for depression history, liver function, and BMD before starting; monitor quarterly. Drug interactions abound with rifampin (reduces levels) or over 50 others like clarithromycin—inform physicians fully. Breastfeeding lacks safety data; weigh risks. Regular blood/urine tests track efficacy and safety.\n​\n\nDosage Guidelines\nInitiate Eligolux200 at 150mg daily for milder cases, escalating to 200mg BID for dyspareunia or severe pain, max 6 months at higher dose. Miss a dose? Take promptly unless near next; never double. Duration caps at 24 months total, with liver-adjusted lower dosing. Pair with add-back for extended use to curb BMD loss.\n​\n\nPhysicians tailor based on response: 74-77% complete 6-month trials. Swallow intact; no crushing.\n​\n\nClinical Evidence\nPhase III trials (Elaris EM-I/II) randomized 1689 women, proving both doses superior to placebo for co-primary endpoints of dysmenorrhea and nonmenstrual pain. Open-label extensions to 24 weeks maintained gains. A 12-month study with add-back showed persistent relief and <1% additional BMD loss versus placebo. Real-world use echoes this, positioning Eligolix as first oral GnRH antagonist approved for endometriosis.\n​\n\nVersus relugolix, Eligolix offers comparable pelvic pain reduction with adjustable dosing. Indian brands like Eligolux200 align with global standards.\n​\n\nConclusion\nEligolux200 transforms endometriosis management, delivering substantial pain relief and functional gains through precise hormonal control. Balancing robust benefits against manageable risks like BMD monitoring empowers women toward symptom-free lives. Consult healthcare providers for personalized integration into care plans.\n", "price": 1.0, "discountamount": 0.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2251, "imageuri": "https://productimages.withfloats.com/actual/6948f4f0fe408c85572e7619.png", "tileimageuri": "https://productimages.withfloats.com/tile/6948f4f0fe408c85572e7619.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T07:36:14.316Z", "updatedon": "2025-12-22T10:26:35.194Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/elagolix-tablets-200mg-/2251", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ELIGOLUX 200", "category": "Gynaecology", "tags": [ "Elagolix Tablets 200mg", "Elagolix acts as a potent gonadotropin-releasing hormone.", "nonmenstrual pelvic pain.", "adhesions, and scarring", "preserving bone health better than monotherapy.", "avoiding invasive laparoscopies and reclaiming normalcy.", "pituitary gland to rapidly reduce estrogen and progesterone." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6948e738796e72bd2659934b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Micronized Purified Flavonoid Fraction MPFF Tablets 450mg Diosmin+50mg Hesperidin", "description": "Product Name: FLAVOSHIELD 500\nActive Ingredients: Micronized Purified Flavonoid Fraction (MPFF) 500mg, containing Diosmin 450mg and Hesperidin 50mg.\nPresentation: Oral Tablets\n\nUnveiling FLAVOSHIELD 500: A Deep Dive into Advanced Venous and Vascular Wellness\nIn the intricate network of the human circulatory system, veins perform the silent, relentless task of returning blood to the heart against gravity. When this system faces strain, it can manifest through discomfort, heaviness, and visible changes that impact both physical well-being and quality of life. Enter FLAVOSHIELD 500, a sophisticated pharmaceutical-grade formulation designed to fortify venous health at its core. Powered by a Micronized Purified Flavonoid Fraction (MPFF)—a precise blend of 450mg Diosmin and 50mg Hesperidin—FLAVOSHIELD 500 represents a pinnacle in venoactive therapy. This comprehensive description explores the product, its mechanism, multifaceted uses, key benefits, safety profile, and its role in a holistic health strategy.\n\nWhat is FLAVOSHIELD 500? The Science of MPFF\nFLAVOSHIELD 500 is not a simple herbal supplement; it is a clinically researched, standardized medical treatment. Its active core, the Micronized Purified Flavonoid Fraction, is derived from citrus fruits but undergoes a specialized purification and micronization process. This technological advancement is crucial:\n\nPurification: Ensures a consistent, high-potency concentration of the active flavonoid molecules, Diosmin and Hesperidin, free from plant impurities.\nMicronization: Reduces the particle size of the flavonoids dramatically, increasing their surface area. This leads to significantly enhanced absorption in the gastrointestinal tract, ensuring that a much higher percentage of the active dose reaches the bloodstream and, ultimately, the target venous tissues. Compared to non-micronized diosmin, MPFF offers up to 30% greater bioavailability, making FLAVOSHIELD 500 a more effective and reliable choice.\nThis synergy of Diosmin and Hesperidin works on multiple physiological pathways to restore venous tone and capillary integrity.\n\nPrimary Uses and Therapeutic Applications\nFLAVOSHIELD 500 is indicated for the management of various stages of chronic venous disorders and related conditions:\n\nChronic Venous Disease (CVD) & Venous Insufficiency: This is the primary use. It alleviates the distressing symptoms stemming from weakened vein walls and faulty valves in the legs. These include:\n\nHeaviness and Fatigue: The pervasive feeling of weight and tiredness in the legs, especially after prolonged standing or sitting.\nPain and Aching: Dull, throbbing, or cramping pain that improves with elevation.\nSwelling (Edema): Reduction of ankle and lower leg swelling caused by fluid leakage from capillaries.\nNocturnal Cramps: Relief from painful muscle spasms that often occur at night.\nHemorrhoidal Disease (Acute and Chronic): MPFF is a cornerstone in hemorrhoid management. It treats acute hemorrhoidal attacks by reducing bleeding, pain, and discharge. For chronic cases, it helps prevent recurrences by decreasing capillary fragility and inflammation in the anal venous plexus.\n\nPost-Phlebitic Syndrome: Following deep vein thrombosis (DVT), patients often suffer from chronic leg swelling, pain, and skin changes. FLAVOSHIELD 500 can be part of the management plan to improve microcirculation and reduce symptoms.\n\nSupport Post-Sclerotherapy or Surgical Procedures: It is commonly used after vein stripping, laser ablation, or sclerotherapy to support healing, reduce postoperative swelling and bruising, and help consolidate results.\n\nKey Benefits and Mechanism of Action: The Multi-Target Approach\nThe efficacy of FLAVOSHIELD 500 stems from its multi-faceted pharmacological actions on the venous and lymphatic systems:\n\nVenotonic Action: It increases venous tone and elasticity by promoting the contraction of smooth muscle in the vein walls. This helps veins propel blood more efficiently upward, reducing pooling and pressure. Think of it as “tightening” slackened venous structures.\n\nCapillary-Protective & Anti-Inflammatory Effects: It strengthens capillary walls (reduces capillary permeability) and inhibits the release of inflammatory mediators (like prostaglandins and leukotrienes). This dual action minimizes the leakage of fluid, proteins, and inflammatory cells into surrounding tissues, thereby directly addressing edema (swelling) and inflammation. This is particularly vital in hemorrhoidal tissue.\n\nLymphatic Enhancement: FLAVOSHIELD 500 has been shown to increase lymphatic drainage by boosting the frequency and intensity of lymphatic contractions. This provides an additional route for removing excess interstitial fluid and proteins, further reducing swelling.\n\nAntioxidant Activity: The flavonoids scavenge harmful free radicals, protecting venous and capillary endothelial cells from oxidative stress, which is a contributing factor in chronic venous disease.\n\nImprovement of Microcirculation: By reducing blood viscosity and inhibiting red blood cell aggregation, it improves blood flow in the smallest vessels, enhancing oxygen delivery and waste removal at the tissue level.\n\nPatient-Centric Benefits:\n\nRapid Symptom Relief: Patients often report a noticeable decrease in leg heaviness and pain within the first few weeks of treatment.\nEnhanced Quality of Life: Restores the ability to stand, walk, and engage in daily activities with greater comfort and less discomfort.\nReduced Reliance on Pain Medication: By addressing the underlying inflammation and pain of venous issues and hemorrhoids, it can decrease the need for NSAIDs.\nComplement to Compression Therapy: Works synergistically with compression stockings, often allowing for better tolerance and compliance with compression wear.\nSide Effects and Safety Profile: What to Expect\nFLAVOSHIELD 500 is generally very well-tolerated, with a low incidence of side effects, which are typically mild and transient. This excellent safety profile is a result of its natural origin and high purification.\n\nCommon Side Effects (Rare and usually mild):\n\nGastrointestinal: Some individuals may experience mild, transient digestive disturbances such as nausea, stomach pain, diarrhea, or heartburn. Taking the tablet with a meal can often mitigate this.\nNeurological: Occasional reports of headache or dizziness.\nAllergic Reactions: Very rare cases of skin rash or itching have been reported.\nImportant Safety Considerations:\n\nPregnancy and Lactation: While no teratogenic effects have been demonstrated, as a precaution, use during pregnancy (especially the first trimester) and breastfeeding should only be under the direct supervision of a physician who has weighed the benefits against potential risks.\nDrug Interactions: No significant pharmacokinetic drug interactions have been formally reported. However, as with any medication, it is prudent to inform your doctor about all other medicines and supplements you are taking.\nContraindications: Hypersensitivity to any of the components (Diosmin, Hesperidin, or excipients in the tablet) is a contraindication.\nCrucial Note: FLAVOSHIELD 500 is a treatment for symptoms and a stabilizer of venous function, not a cure for underlying venous valve incompetence. It does not replace definitive interventional treatments (like ablation or surgery) for advanced varicose veins when they are medically indicated. It is essential to receive a proper diagnosis from a healthcare professional to rule out other causes of leg swelling or pain (e.g., cardiac, renal, or hepatic origin).\n\nConclusion: FLAVOSHIELD 500 – A Cornerstone of Comprehensive Venous Care\nIn conclusion, FLAVOSHIELD 500 stands as a robust, scientifically validated agent in the realm of vascular health. Its advanced MPFF technology, combining 450mg of micronized Diosmin with 50mg of Hesperidin, delivers enhanced bioavailability and a powerful, multi-target action that addresses the root causes of venous discomfort: poor tone, capillary fragility, inflammation, and impaired lymphatic drainage.\n\nWhether battling the daily fatigue of heavy legs, managing the acute distress of a hemorrhoidal flare-up, or supporting recovery after a venous procedure, FLAVOSHIELD 500 offers a reliable and well-tolerated therapeutic option. Its benefits in improving symptoms and quality of life are clear, backed by a strong body of clinical evidence.\n\nHowever, optimal venous health is a holistic endeavor. FLAVOSHIELD 500 should be viewed as the pharmacological cornerstone of a broader management plan. This plan should include:\n\nMedical Supervision: Regular consultation with a vascular specialist or phlebologist.\nLifestyle Modifications: Weight management, regular low-impact exercise (walking, swimming), and elevation of the legs.\nCompression Therapy: The use of medically prescribed compression stockings when recommended.\nDietary Awareness: A fiber-rich diet to prevent constipation and straining.\nBy integrating FLAVOSHIELD 500 into this comprehensive approach, individuals can take proactive control of their venous health, shielding their vitality and comfort from the burdens of venous insufficiency. Always consult your healthcare provider to determine if FLAVOSHIELD 500 is appropriate for your specific condition and to establish the correct dosage and treatment duration.\n\nDisclaimer: This content is for informational purposes only and does not constitute medical advice. Always seek the guidance of a qualified healthcare professional with any questions regarding a medical condition or treatment. Do not delay seeking or disregard professional medical advice based on information contained here.", "price": 218.0, "discountamount": 66.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2250, "imageuri": "https://productimages.withfloats.com/actual/6948e7392f14bd83555d1409.png", "tileimageuri": "https://productimages.withfloats.com/tile/6948e7392f14bd83555d1409.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-22T06:37:44.038Z", "updatedon": "2025-12-22T10:26:13.147Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/micronized-purified-flavonoid-fraction-mpff-tablets-450mg-diosmin-50mg-hesperidin/2250", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "FLAVOSHIELD 500", "category": "GENERAL RANGE", "tags": [ "A Deep Dive into Advanced Venous and Vascular Wellness", "human circulatory system", "blood to the heart against gravity.", "Powered by a Micronized Purified Flavonoid Fraction (MPFF)", "Hemorrhoidal Disease", "By reducing blood viscosity and inhibiting red blood cell aggregation", "holistic health strategy.", "Chronic Venous Insufficiency (CVI)", "Varicose Veins", "Hemorrhoids (Piles)", "Venous Ulcers", "Lymphedema", "Post-Surgical Venous Recovery" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }